本页面由Tiger Trade Technology Pte. Ltd.提供服务

Bicara Therapeutics

17.50
+0.24001.39%
盘后:17.500.00000.00%19:30 EDT
成交量:71.60万
成交额:1,256.01万
市值:11.58亿
市盈率:-5.63
高:17.82
开:17.19
低:16.88
收:17.26
52周最高:30.99
52周最低:13.70
股本:6,617.29万
流通股本:3,676.23万
量比:0.79
换手率:1.95%
股息:- -
股息率:- -
每股收益(TTM):-3.1097
每股收益(LYR):-2.5230
净资产收益率:-41.01%
总资产收益率:-26.14%
市净率:2.47
市盈率(LYR):-6.94

数据加载中...

2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]